Ajanta Pharma rose 3.16% to Rs 1094 at 9:55 IST on BSE, with the stock extending Monday's 8.46% rally triggered by the company reporting strong Q4 earnings.
Meanwhile, the S&P BSE Sensex was up 123.56 points or 0.55% at 22,568.68.
On BSE, so far 44,000 shares were traded in the counter as against average daily volume of 56,000 shares in the past two weeks.
The stock hit a high of Rs 1115.05 and a low of Rs 1070.55 so far during the day. The stock had hit a record high of Rs 1,138.60 on Monday, 5 May 2014. The stock had hit a 52-week low of Rs 475.34 on 28 August 2013.
Shares of Ajanta Pharma have surged 11.9% in two trading sessions from a recent low of Rs 977.65 on 2 May 2014, after the company during trading hours on Monday, 5 May 2014, reported strong Q4 March 2014 earnings. The stock had rallied 8.46% to settle at Rs 1,060.45 on Monday, 5 May 2014.
Ajanta Pharma's profit after tax (PAT) jumped 159% to Rs 70 crore on 25% growth in revenue from operations to Rs 311 crore in Q4 March 2014 over Q4 March 2013.
Ajanta Pharma's EBITDA (earnings before interest, taxation, depreciation and amortization) surged 63% to Rs 112 crore in Q4 March 2014 over Q4 March 2013.
Exports contributed 66% of the total operating income in Q4 March 2014, Ajanta Pharma said.
Ajanta Pharma's PAT surged 118% to Rs 221 crore on 32% growth in revenue from operations to Rs 1110 crore in the year ended 31 March 2014 (FY 2014) over the year ended 31 March 2013 (FY 2013).
EBITDA jumped 65% to Rs 346 crore in FY 2014 over FY 2013.
Exports contributed 63% of the total operating income for FY 2014, Ajanta Pharma said.
On consolidated basis, Ajanta Pharma's profit after tax jumped 109% to Rs 234 crore on 30% growth in revenue from operations to Rs 1208 crore in FY 2014 over FY 2013.
EBITDA jumped 64% to Rs 369 crore in FY 2014 over FY 2013.
Ajanta Pharma's board of directors at its meeting held on Monday, 5 May 2014, recommended dividend of Rs 10 per share, subject to approval of shareholders at the ensuing Annual General Meeting to be held in 2014.
Ajanta Pharma - a speciality pharmaceutical formulation company has leading brands in therapeutic segments of ophthalmology, dermatology, cardiology and pain management
Powered by Capital Market - Live News
